Inactief instrument

Andere talen Freeline Therapeutics Holdings plc

Aandelen

FRLN

US35655L2060

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting	24/04
Syncona’s Takeover of Freeline Therapeutics Becomes Effective	20/02
Freeline Therapeutics Holdings plc Announces Resignation of Julia Gregory, Martin Andrews, Jeffrey Chodakewitz, Colin Love and Paul Schneider from the Board	20/02
Acquisition of Freeline by Syncona Becomes Effective	20/02
Freeline Therapeutics Holdings plc(NasdaqCM:FRLN) dropped from NASDAQ Composite Index	20/02
Syncona Investment Management Limited completed the acquisition of the remaining 42.08% stake in Freeline Therapeutics Holdings plc.	20/02
Freeline shareholders approve Syncona acquisition	12/02
Freeline Therapeutics' Shareholders Approve Acquisition by Syncona	12/02
Freeline Shareholders Approve Acquisition by Syncona	12/02
Syncona says Freeline trial for Gaucher disease treatment positive	19/01
European Equities Traded in the US as American Depositary Receipts Gain Friday	22/12
Pharma und Gesundheit: weitere Konsolidierung	13/12
Farmaceutica e salute: continua il consolidamento	11/12
Farmacia y salud: La consolidación continúa	11/12
Pharma & santé : poursuite de la consolidation	11/12
Hemophilia Pipeline, FDA Approvals, Clinical Trials Developments and Companies 2023 \| Centessa Pharmaceuticals, Alnylam Pharmaceuticals, ASC Therapeutics, Spark Therapeutics, Freeline Therapeutics	08/12
Freeline Therapeutics : Reports Second Quarter 2023 Financial Results and Business Highlights - Form 6-K	01/12
Freeline Therapeutics Holdings plc Reports Earnings Results for the Nine Months Ended September 30, 2023	01/12
FREELINE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Freeline Therapeutics Holdings plc - FRLN	28/11
Sector Update: Health Care Stocks Advance Late Afternoon	22/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Freeline Therapeutics Holdings plc

Aandelen

FRLN

US35655L2060

Andere talen

Filters